Early intervention (EI) in rare diseases is critical for improving outcomes, particularly in individuals with concurrent disabilities. With over 7,000 known rare diseases affecting approximately 300 million people globally, early diagnosis remains a challenge, with an average diagnostic delay of 4–5 years. Studies show that EI can enhance cognitive, motor, and social development, reducing long-term healthcare costs and improving quality of life. For children with rare diseases and disabilities, EI services—such as physical, occupational, and speech therapies—can mitigate progression, enhance adaptive skills, and promote independence. Despite its benefits, barriers include limited awareness, access to specialized care, and insurance coverage. Advancing EI through newborn screening, genetic testing, and multidisciplinary care can significantly impact disease trajectory and long-term outcomes, necessitating policy reforms and increased research investment.
Learning Outcomes
- Understand the Prevalence and Challenges of Rare Diseases
- Recognize the Benefits of Early Intervention
- Explore Strategies for Advancing Early Diagnosis and Care